Journal of the American Chemical Society
Article
solvent was removed under reduced pressure to afford an orange oil
4d (1.5 g, 88% yield). NMR spectra: H NMR (400 MHz, CDCl3) δ
mixture was stirred for 3 h. The solvent was removed under vacuo,
hexane (40 mL) was added, and the dark-yellow mixture was filtered
through a pad of Celite under Ar. The solvent was removed under
1
7.89 (dd, 3JH,H = 7.5 Hz, 4JP,H = 0.7 Hz, 1H, Py-Hm), 7.60 (t, 3JH,H = 8
Hz, 1H, Py-Hp), 7.37−7.26 (m, 2H, Ar-Ho), 7.12−7.07 (m, 1H, Ar-
Hp), 6.94 (d, 3JH,H = 8.1 Hz, 1H, Py-Hm′), 6.82−6.79 (m, 2H, Ar-Hm),
2.31 (s, 3H, NCMe), 1.23 (d, 3JP,H = 11.7 Hz, 18H, CMe3); 31P{1H}
NMR (162 MHz, CDCl3) δ 155.4 (s); 13C{1H} NMR (101 MHz,
CDCl3) δ 167.7 (N = C), 163.9 (d, 2JP,C = 7.6 Hz, Py-Co), 155.1 (Py-
Co′), 151.5 (Ar-Cip), 139.3 (Py-Cp), 129.0 ((Ar-Co)), 123.5 (Ar-Cp),
1
reduced pressure to afford a yellow solid 4g (1.8 g, 99% yield). H
NMR (400 MHz, CDCl3) δ 8.00 (d, 3JH,H = 7.5 Hz, 1H, Py-Hm), 7.69
(t, 3JH,H = 7.8 Hz, 1H, Py-Hp), 7.06−6.90 (m, 4H, Py-Hm′, Ar-H), 2.15
(s, 3H, NCMe), 2.02 (s, 6H, Ar-Me), 1.16−1.07 (m, 14H, PCH,
CHMe2); 31P{1H} NMR (162 MHz, CDCl3) δ 146.7 (s); 13C{1H}
2
NMR (101 MHz, CDCl3) δ 167.2 (N = C), 163.3 (d, JP,C = 6.1 Hz,
Py-Co), 154.5 (d, 4JP,C = 1.2 Hz, Py-Co′), 148.9 (Ar-Cip), 139.3 (d, 4JP,C
= 1.1 Hz, Py-Cp), 127.9 (Ar-Co), 125.6 (Ar-Cp), 123.0 (Ar-Cm), 115.1
3
119.4 (Ar-Cm), 115.3 (Py-Cm′), 113.8 (d, JP,C = 2.3 Hz, Py-Cm), 35.7
(d, 1JP,C = 27.0 Hz, CMe3), 27.7 (d, 2JP,C = 15.7 Hz, CMe3), 16.8 (N
CMe). HRMS (EI), m/z Calcd for C21H29N2OP (M+) 356.2018,
found: 356.2023.
3
1
(Py-Cm′), 113.6 (d, JP,C = 1.9 Hz, Py-Cm), 28.0 (d, JP,C = 18.8 Hz,
CHMe2), 18.1 (d, 2JP,C = 20.6 Hz, PCH), 18.0 (Ar-Me), 17.5 (d, 2JP,C
=
iPrPNNiPr Ligand, (E)-N-(1-(6-((Diisopropylphosphino)oxy)pyridin-
2-yl)ethylidene)-2,6-diisopropylaniline (4e). Under an atmosphere of
argon, NaH (71.0 mg, 3.0 mmol, 1.1 equiv) and THF (15 mL) were
added to a 100 mL Schlenk tube. The solution of (E)-6-(1-((2,6-
diisopropylphenyl)imino)ethyl)pyridin-2-ol (3a) (0.8 g, 2.7 mmol, 1
equiv) in THF (10 mL) was added dropwise to the Schlenk tube at
room temperature. After that the mixture was stirred for 10 min,
iPr2PCl (450 mg, 3.0 mmol, 1.1 equiv) was added, and the resulting
mixture was stirred for 3 h. The solvent was removed under vacuo,
hexane (30 mL) was added, and the dark-yellow mixture was filtered
through a pad of Celite under Ar. The solvent was removed under
9.3 Hz, CHMe2), 16.9 (NCMe). HRMS (EI), m/z Calcd for
C21H29N2OP (M+) 356.2018, found: 356.2021.
iPrPNNH Ligand, (E)-N-(1-(6-((Diisopropylphosphino)oxy)pyridin-
2-yl)ethylidene)aniline (4h). Under an atmosphere of argon, NaH
(84.0 mg.0, 3.5 mmol, 1.1 equiv) and THF (10 mL) were added to a
100 mL Schlenk tube. The solution of (E)-6-(1-(phenylimino)ethyl)-
pyridin-2-ol (3d) (676.0 mg, 3.2 mmol, 1 equiv) in THF (20 mL) was
added dropwise to the Schlenk tube at room temperature. After that
the mixture was stirred for 10 min, iPr2PCl (534.0 mg, 3.5 mmol, 1.1
equiv) was added, and the resulting mixture was stirred for 3 h. The
solvent was removed under vacuo, hexane (25 mL) was added, and the
brown mixture was filtered through a pad of Celite under Ar. The
solvent was removed under reduced pressure to afford an orange oil
1
reduced pressure to afford a yellow solid 4e (1.0 g, 92% yield). H
3
4
NMR (400 MHz, CDCl3) δ 7.99 (dd, JH,H = 7.5 Hz, JP,H = 0.7 Hz,
1
3
4h (910.0 mg, 87% yield). H NMR (400 MHz, CDCl3) δ 7.89 (d,
1H, Py-Hm), 7.70 (t, JH,H = 7.8 Hz, 1H, Py-Hp), 7.16−7.06 (m, 3H,
Ar-H), 6.92 (d, JH,H = 8.1 Hz, 1H, Py-Hm′), 2.79−2.69 (m, 2H,
3
3JH,H = 7.5 Hz, 1H, Py-Hm), 7.67 (t, JH,H = 7.8 Hz, 1H, Py-Hp), 7.35
3
3
3
CHMe2), 2.18 (s, 3H, NCMe), 2.10−1.99 (m, 2H, CHMe2), 1.24−
1.10 (m, 24H, CHMe2); 31P{1H} NMR (162 MHz, CDCl3) δ 146.8
(s); 13C{1H} NMR (101 MHz, CDCl3) δ 166.9 (N = C), 163.4 (d,
2JP,C = 6.1 Hz, Py-Co), 154.6 (d, 4JP,C = 1.1 Hz, Py-Co′), 146.7 (Ar-Cip),
(t, JH,H = 7.8 Hz, 2H, Ar-Hm), 7.09 (t, JH,H = 7.4 Hz, 1H, Ar-Hp),
3
3
6.89 (d, JH,H = 8.1 Hz, 1H, Py-Hm′), 6.80 (d, JH,H = 7.6 Hz, 2H, Ar-
Ho), 2.32 (s, 3H, NCMe), 2.13−1.87 (m, 2H, CHMe2), 1.22−1.13
(m, 12H, CHMe2); 31P{1H} NMR (162 MHz, CDCl3) δ 146.5 (s);
13C{1H} NMR (101 MHz, CDCl3) δ 167.3 (N = C), 163.2 (d, 2JP,C
=
3
139.3 (d, JP,C = 1.9 Hz, Py-Cm), 136.0 (Ar-Co), 123.6 (Ar-Cp), 123.1
(Ar-Cm), 115.1 (Py-Cm′), 113.5 (d, JP,C = 0.8 Hz, Py-Cp), 28.3
6.1 Hz, Py-Co), 154.9 (d, 4JP,C = 1.1 Hz, Py-Co′), 151.5 (Ar-Cip), 139.3
(Py-Cp), 129.0 (Ar-Co), 123.5 (Ar-Cp), 119.3 (Ar-Cm), 115.2 (Py-Cm′),
4
1
(CHMe2), 28.1 (d, JP,C = 19.1 Hz, PCH), 23.3 (CHMe2), 23.0
2
3
1
(CHMe2), 18.1 (d, JP,C = 20.6 Hz, PCHMe2), 17.6 (NCMe), 17.5
113.5 (d, JP,C = 1.6 Hz, Py-Cm), 28.0 (d, JP,C = 19.1 Hz, CHMe2),
2
2
2
(d, JP,C = 9.7 Hz, PCHMe2). HRMS (ESI), m/z Calcd for
18.1 (d, JP,C = 20.5 Hz, CHMe2), 17.5 (d, JP,C = 9.3 Hz, CHMe2),
16.7 (NCMe). HRMS (EI), m/z Calcd for C19H25N2OP (M+)
328.1705, found: 328.1708.
C25H37N2OP (M + H)+ 413.2722, found: 413.2716.
iPrPNNEt Ligand, (E)-N-(1-(6-((Diisopropylphosphino)oxy)pyridin-
2-yl)ethylidene)-2,6-diethylaniline, (4f). Under an atmosphere of
argon, NaH (120.0 mg, 5.0 mmol, 1.1 equiv) and THF (20 mL) were
added to a 100 mL Schlenk tube. The solution of (E)-6-(1-((2,6-
diethylphenyl)imino)ethyl)pyridin-2-ol (3b) (1.2 g, 4.6 mmol, 1
equiv) in THF (30 mL) was added dropwise to the Schlenk tube at
room temperature. After that the mixture was stirred for 10 min,
iPr2PCl (763.0 mg, 5.0 mmol, 1.1 equiv) was added, and the resulting
mixture was stirred for 3 h. The solvent was removed under vacuo,
hexane (30 mL) was added, and the dark-yellow mixture was filtered
through a pad of Celite under Ar. The solvent was removed under
(
tBuPNNiPr)FeCl2 (5a). In a N2-filled glovebox, ligand 4a (1.2 g, 2.8
mmol) was added to a solution of FeCl2 (350.0 mg, 2.8 mmol) in
THF (60 mL) at room temperature with vigorous stirring. The
colorless solution turned to a dark-blue suspension immediately. After
being stirred at room temperature for 24 h, the solution was reduced
to about 10 mL via evaporation under vacuo. Then the suspension was
filtered, and the resulting solid was washed with 20 mL ether and dried
under vacuo. The product was obtained as a dark-blue powder (1.4 g,
90% yield). The complex 5a was dissolved in a mixture of
dichloromethane and tetrahydrogenfuran. The solvent evaporated
slowly at room temperature in the N2-filled glovebox. After a few days,
dark-green crystals of complex 5a were obtained for X-ray analysis. 1H
NMR (300 MHz, CD2Cl2) δ 87.5 (81.9, 1H), 59.1 (78.4, 1H), 58.0
(49. 7, 1H), 11.2 (118.0, 18H, CMe3), 8.1 (34.0, 3H, NCMe), 3.1
(22.0, 12H, CHMe2), −5.93 (7.0, 1H), −10.9 (65.2, 2H, CHMe2),
−12.0 (31.0, 1H), −12.5 (34.6, 1H). Anal. Calcd for
C27H41Cl2FeN2OP: C, 57.16, H, 7.28, N, 4.94. Found: C, 57.32, H,
7.42, N, 6.68. μeff (Evan’s method, CDCl3, 25 °C) = 5.3 μB.
1
reduced pressure to afford a yellow solid 4f (1.5 g, 87% yield). H
3
NMR (400 MHz, CDCl3) δ 7.99 (d, JH,H =7.5 Hz, 1H, Py-Hm),
7.69(t, 3JH,H = 7.8 Hz, 1H, Py-Hp), 7.11−6.99 (m, 3H, Ar−H), 6.92 (d,
3JH,H = 8.1 Hz, 1H, Py-Hm′), 2.44−2.27 (m, 4H, CH2Me), 2.16 (s, 3H,
NCMe), 2.10−1.98 (m, 2H, CHMe2), 1.23−1.11 (m, 18H, CH2Me,
CHMe2); 31P{1H} NMR (162 MHz, CDCl3) δ 146.9 (s); 13C{1H}
2
NMR (101 MHz, CDCl3) δ 166.9 (N = C), 163.4 (d, JP,C = 6.1 Hz,
Py-Co), 154.6 (d, 4JP,C = 1.2 Hz, Py-Co′), 148.0 (Ar-Cip), 139.3 (d, 4JP,C
= 1.2 Hz, Py-Cp), 131.4 (Ar-Co), 126.0 (Ar-Cp), 123.3 (Ar-Cm), 115.1
(
tBuPNNEt)FeBr2 (5b). In a N2-filled glovebox, ligand 4b (654.0 mg,
3
1
1.6 mmol, 1 equiv) was added to a solution of FeBr2 (342.0 mg, 1.6
mmol, 1 equiv) in THF (50 mL) at room temperature with vigorous
stirring. The orange solution turned to dark blue immediately. Then
the reaction flask was sealed and heated in an oil bath. After being
stirred at 80 °C for 16 h, the reaction solution was cooled to room
temperature. The solvent was removed under vacuo. Then 10 mL
ether was added, and the resulting suspension was filtered. The solid
was washed with 10 mL ether and dried in vacuo. The product was
(Py-Cm′), 113.5 (d, JP,C = 1.9 Hz, Py-Cm), 28.1 (d, JP,C = 19.1 Hz,
2
PCH), 24.7 (CH2Me), 18.2 (d, JP,C = 20.4 Hz, CHMe2), 17.6 (M =
CMe), 17.4 (d, 2JP,C = 21.2 Hz, CHMe2), 13.8 (CH2Me). HRMS (EI),
m/z Calcd for C21H29N2OP (M+) 356.2018, found: 356.2021.
iPrPNNMe Ligand, (E)-N-(1-(6-((Diisopropylphosphino)oxy)pyridin-
2-yl)ethylidene)-2,6-dimethylaniline (4g). Under an atmosphere of
argon, NaH (144.0 mg, 6.0 mmol, 1.1 equiv) and THF (20 mL) were
added to a 100 mL Schlenk tube. The solution of (E)-6-(1-((2,6-
dimethylphenyl)imino)ethyl)pyridin-2-ol (3c) (1.3 g, 5.5 mmol, 1
equiv) in THF (30 mL) was added dropwise to the Schlenk tube at
room temperature. After that the mixture was stirred for 10 min,
iPr2PCl (920.0 mg, 6.0 mmol, 1.1 equiv) was added, and the resulting
1
obtained as a gray powder (880.0 mg, 88% yield). H NMR (300
MHz, CD2Cl2) δ 85.2 (8.9, 1H), 61.6 (72.3, 2H), 55.3 (45.4, 1H),
13.6 (114.1, 18H, CMe3), 8.7 (27.2, 3H, NCMe), 1.2 (17.1, 4H,
CH2Me), −1.0 (34.0, 6H, CH2Me), −13.6 (24.5, 1H), −15.2 (38.5,
J
dx.doi.org/10.1021/ja404963f | J. Am. Chem. Soc. XXXX, XXX, XXX−XXX